Kinetic, spectroscopic and thermodynamic characterization of the Mycobacterium tuberculosis adrenodoxin reductase homologue FprA

Biochemical Journal

Volumn 372, Issue 2, 2003, Pages 317-327

  McLean, Kirsty J ^a   Scrutton, Nigel S ^a   Munro, Andrew W ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Adrenodoxin reductase; Flavoprotein; FprA; Potentiometry; Stopped flow kinetics

Indexed keywords

ENZYMES; ESCHERICHIA COLI; GENES; KETONES; REDUCTION; SPECTROPHOTOMETRY; TITRATION;

GENOME SEQUENCE;

GENETIC ENGINEERING;

CYTOCHROME P450 REDUCTASE; DITHIONITE; FERREDOXIN NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE REDUCTASE; FERRICYANIDE; FLAVINE ADENINE NUCLEOTIDE; FLAVOPROTEIN; HYDROQUINONE; PROTEIN; PROTEIN FPRA; PYRIDINE NUCLEOTIDE; QUERCETIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SEMIQUINONE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CONCENTRATION (PARAMETERS); ELECTRON; ELECTRON SPIN RESONANCE; ENZYME STRUCTURE; ESCHERICHIA COLI; KINETICS; MICHAELIS CONSTANT; MOLECULAR CLONING; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE BINDING SITE; PH ELECTRODE; PRIORITY JOURNAL; SPECTROPHOTOMETRY; STEADY STATE; THERMODYNAMICS; TITRIMETRY;

BINDING SITES; CATALYTIC DOMAIN; CIRCULAR DICHROISM; CLONING, MOLECULAR; ELECTRON SPIN RESONANCE SPECTROSCOPY; ELECTRON TRANSPORT; ESCHERICHIA COLI; FERREDOXIN-NADP REDUCTASE; FERREDOXINS; FERRICYANIDES; FLAVIN-ADENINE DINUCLEOTIDE; KINETICS; MYCOBACTERIUM TUBERCULOSIS; NAD; NADH, NADPH OXIDOREDUCTASES; NADP; OXIDATION-REDUCTION; OXIDOREDUCTASES; PROTEIN BINDING; RECOMBINANT PROTEINS; SPECTROPHOTOMETRY, ULTRAVIOLET; THERMODYNAMICS;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); CANIS; ESCHERICHIA COLI; EUKARYOTA; LIA; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 0038000590     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20021692     Document Type: Article

References (45)

1. Anti-tuberculosis drug resistance in the world (1997) The WHO/IUTALD global project on anti-tuberculosis drug resistance surveillance, WHO (http://www.who.int/gtb/publications/dritw/index.htm)
2. Zhang, Y. and Young, D. B. (1993) Molecular mechanisms of isoniazid: a drug at the front line of tuberculosis control. Trends Microbiol. 1, 109-113
3. Baulard, A. R., Betts, J. C., Engohang-Ndong, J., Quan, S., McAdam, R. A., Brennan, P. J., Locht, C. and Besra, G. S. (2000) Activation of the pro-drug ethionamide is regulated in mycobacteria. J. Biol. Chem. 275, 28326-28331
4. Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E. et al. (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature (London) 393, 537-544
5. Daffe, M. and Draper, P. (1998) The envelope layers of mycobacteria with reference to their pathogenicity. Adv. Microbial. Physiol. 39, 131-203
6. Podust, L. M., Poulos, T. L. and Waterman, M. R. (2001) Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc. Natl. Acad. Sci. U.S.A. 98, 3068-3073
7. Leys, D., Mowat, C. G., McLean, K. J., Richmond, A., Chapman, S. K., Walkinshaw, M. D. and Munro, A. W. (2003) Atomic structure of Mycobacterium tuberculosis CYP121 to 1.06 Å reveals novel features of cytochrome P450. J. Biol. Chem. 278, 5141-5147
8. Bentley, S. D., Chater, K. F., Cerdeno-Tarraga, A. M., Challis, G. L., Thomson, N. R., James, K. D., Harris, D. E., Quail, M. A., Kieser, H., Harper, D. et al. (2002) Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature (London) 417, 141-147
9. McLean, K. J., Marshall, K. R., Richmond, A., Hunter, I. S., Fowler, K., Kieser, T., Gurcha, S. S., Besra, G. S. and Munro, A. W. (2002) Azole antifungals are potent inhibitors of cytochromes P450 and bacterial growth in mycobacteria and streptomycetes. Microbiology 148, 2937-2949
10. McLean, K. J., Cheesman, M. R., Rivers, S. L., Richmond, A., Leys, D., Chapman, S. K., Reid, G. A., Price, N. C., Kelly, S. M., Clarksen, J. et al. (2002) Expression, purification and spectroscopic characterization of the cytochrome P450 CYP121 from Mycobacterium tuberculosis. J. Inorg. Biochem. 91, 527-541
11. Guengerich, F. P., Hosea, N. A., Parikh, A., Bell-Parikh, L. C., Johnson, W. W., Gillam, E. M. J. and Shimada, T. (1998) Twenty years of biochemistry of human P450s: purification, expression, mechanism, and relevance to drugs. Drug Met. Dispos. 26, 1175-1178
12. Gutierrez, A., Lian, L. Y., Wolf, C. R., Scrutton, N. S. and Roberts, G. C. K. (2001) Stopped-flow kinetic studies of flavin reduction in human cytochrome P450 reductase and its component domains. Biochemistry 40, 1964-1975
13. Munro, A. W. and Lindsay, J. G. (1996) Bacterial cytochromes P450. Mol. Microbiol. 20, 1115-1125
14. Pikuleva, I. A., Mackman, R. L., Kagawa, N., Waterman, M. R. and Ortiz de Montellano, P. R. (1995) Active site topology of bovine cholesterol side chain cleavage cytochrome P450 (P450scc) and evidence for interaction of tyrosine 94 with the side chain of cholesterol. Arch. Biochem. Biophys. 322, 189-197
15. + and NADPH suggesting a mechanism for the electron transfer of an enzyme family. Biochemistry 39, 10986-10995
16. Grinberg, A. V., Hannemann, F., Schiffler, B., Muller, J., Heinemann, U. and Bernhardt, R. (2000) Adrenodoxin: Structure, stability, and electron transfer properties. Proteins: Struct., Funct., Genet. 40, 590-612
17. Muller, J. J., Lapko, A., Bourenkov, G., Ruckpaul, K. and Heinemann, U. (2001) Adrenodoxin reductase-adrenodexin complex structure suggests electron transfer path in steroid biosynthesis. J. Biol. Chem. 276, 2786-2789
18. + revealed by the atomic resolution structure of FprA, a Mycobacterium tuberculosis oxidoreductase. Biochemistry 41, 8807-8818
19. Fischer, F., Raimondi, D., Aliverti, A. and Zanetti, G. (2002) Mycobacterium tuberculosis FprA, a novel bacterial NADPH-ferredoxin reductase. Eur. J. Biochem. 269, 3005-3013
20. Gibson, T. J. (1984) Studies in the Epstein-Barr virus genome. PhD Thesis, University of Cambridge, U.K.
21. Sambrook, J., Fritsch, E. F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
22. Munro, A. W. and Noble, M. A. (1999) Fluorescence analysis of flavoproteins. In Flavoprotein Protocols, (Chapman, S. K. and Reid, G. A., eds), pp. 25-48, Humana Press, Totowa, NJ
23. Munro, A. W., Noble, M. A., Robledo, L., Daff, S. N. and Chapman, S. K. (2001) Determination of the redox properties of human NADPH-cytochrome P450 reductase. Biochemistry 40, 1956-1963
24. Dutton, P. L. (1978) Redex potentiometry: determination of midpoint potentials of oxidation-reduction components of biological electron-transfer systems. Methods Enzymol. 54, 411-435
25. Ost, T. W. B., Miles, C. S., Munro, A. W., Murdoch, J., Reid, G. A. and Chapman, S. K. (2001) Phenylalanine 393 exerts thermodynamic control over the heme of flavocytochreme P450BM3. Biochemistry 40, 13421-13429
26. Tew, D. G. (1993) Inhibition of cytochrome P450 reductase by the diphenyliodonium cation. Kinetic analysis and covalent modifications. Biochemistry 32, 10209-10215
27. + oxidoreductase and flavodoxin; key components of electron transfer in Escherichia coli. Eur. J. Biochem. 257, 577-585
28. Studier, F. W. and Moffatt, B. A. (1986) Use of bacteriophage T7 RNA-polymerase to direct selective high-level expression of cloned genes. J. Mol. Biol. 189, 113-130
29. Reference deleted
30. Suhara, K., Ikeda, Y., Takemeri, S. and Katagiri, M. (1972) The purification and properties of NADPH-adrenedoxin reductase from bovine adrenocortical mitochondria. FEBS Lett. 28, 45-48
31. Pederson, J. I. and Godager, H. K. (1978) Purification of NADPH-ferredoxin reductase from rat liver mitochondria. Biochim. Biophys. Acta 525, 28-33
32. Leadbeater, C., McIver, L., Campepiano, D. J., Webster, S. P., Baxter, R. L., Kelly, S. M., Price, N. C., Lysek, D. A., Noble, M. A., Chapman, S. K. and Munro, A. W. (2000) Probing the NADPH-binding site of Escherichia coli flavodexin oxidoreductase. Biochem. J. 352, 257-266
33. Daff, S. N., Chapman, S. K., Turner, K. L., Holt, R. A., Govindaraj, S., Poulos, T. L. and Munro, A. W. (1997) Redox control of the catalytic cycle of flavocytochrome P-450 BM3. Biochemistry 36, 13816-13823
34. th International Symposium on Flavins and Flavoproteins (Scrutton, N. S., Chapman, S. K. and Perham, R., eds), pp. 605-610, Rudolf Weber, Berlin
35. Murataliev, M. B. and Feyereisen, R. (2000) Interaction of NADP(H) with oxidized and reduced P450 reductase during catalysis, studies with nucleotide analogues. Biochemistry 39, 5066-5074
36. th International Symposium on Flavins and Flavoproteins. (Ghisla, S., Kroneck, P., Macheroux, P. and Sund, H., eds), pp. 891-894, Rudolf Weber, Berlin
37. Gutierrez, A., Paine, M., Wolf, C. R., Scrutton, N. S. and Roberts, G. C. K. (2002) Relaxation kinetics of cytochrome P450 reductase: internal electron transfer is limited by conformational change and regulated by coenzyme binding. Biochemistry 41, 4626-4637
38. Knight, K. and Scrutton, N. S. (2002) Stopped-flow kinetic studies of electron transfer in the reductase domain of neuronal nitric oxide synthase: re-evaluation of the kinetic mechanism reveals new enzyme intermediates and variation with cytochrome P450 reductase. Biochem. J. 367, 19-30
39. Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W. et al. (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmocogenetics 6, 1-42
40. Takeuchi, K., Tsubaki, M., Futagawa, J., Masuya, F. and Hori, H. (2001) Adrenodoxin-cytochreme P450scc interaction as revealed by EPR spectroscopy: comparison with the putidaredoxin-cytochrome P450cam system. J. Biochem. (Tokyo) 130, 789-797
41. Bellamine, A., Mangla, A. T., Nes, W. D. and Waterman, M. R. (1999) Characterization and catalytic properties of the sterol 140α-demethylase from Mycobacterium tuberculosis. Proc. Natl. Acad. Sci U.S.A. 96, 8937-8942
42. Craig, D. H., Chapman, S. K. and Daff, S. (2002) Calmodulin activates electron transfer through neuronal nitric-oxide synthase reductase domain by releasing an NADPH-dependent conformational lock. J. Biol. Chem. 277, 33987-33994
43. Strickland, S., Palmer, G. and Massey, V. (1975) Determination of dissociation constants and specific rate constants of enzyme-substrate (or protein-ligand) interactions from rapid reaction data. J. Biol. Chem. 250, 4048-4052
44. + and NADPH. J. Biol. Chem. 251, 4299-4306
45. Nonaka, Y., Fujii, S. and Yamano, T. (1986) The semiquinone state of NADPH-adrenodoxin reductase in the course of anaerobic reduction with NADPH. J. Biochem. (Tokyo) 99, 803-814